These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31240859)

  • 1. Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury.
    Jin S; Li X; Fan Y; Fan X; Dai Y; Lin H; Cai W; Yang J; Xiang X
    Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):508-517. PubMed ID: 31240859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA-C*03:02 with methimazole-induced liver injury in Graves' disease patients.
    Li X; Jin S; Fan Y; Fan X; Tang Z; Cai W; Yang J; Xiang X
    Biomed Pharmacother; 2019 Sep; 117():109095. PubMed ID: 31202168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.
    Sun Q; Liu HP; Zheng RJ; Wang P; Liu ZB; Sha W; Xiao HP
    Clin Drug Investig; 2017 Dec; 37(12):1125-1136. PubMed ID: 28900877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic examination of methimazole-induced hepatotoxicity in patients with Grave's disease: a metabolomic approach.
    Li X; Yang J; Jin S; Dai Y; Fan Y; Fan X; Li Z; Yang J; Yau WP; Lin H; Cai W; Xiang X
    Arch Toxicol; 2020 Jan; 94(1):231-244. PubMed ID: 31740989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury.
    Li LM; Chen L; Deng GH; Tan WT; Dan YJ; Wang RQ; Chen WS
    Mol Med Rep; 2012 Jul; 6(1):75-82. PubMed ID: 22562052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
    Ulzurrun E; Stephens C; Ruiz-Cabello F; Robles-Diaz M; Saenz-López P; Hallal H; Soriano G; Roman E; Fernandez MC; Lucena MI; Andrade RJ
    PLoS One; 2014; 9(4):e94675. PubMed ID: 24732756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.
    Suzuki N; Noh JY; Hiruma M; Kawaguchi A; Morisaki M; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Iwaku K; Yoshihara A; Watanabe N; Sugino K; Ito K
    Thyroid; 2019 Oct; 29(10):1390-1398. PubMed ID: 31573408
    [No Abstract]   [Full Text] [Related]  

  • 8. Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.
    Ni W; Ji J; Dai Z; Papp A; Johnson AJ; Ahn S; Farley KL; Lin TS; Dalton JT; Li X; Jarjoura D; Byrd JC; Sadee W; Grever MR; Phelps MA
    PLoS One; 2010 Nov; 5(11):e13792. PubMed ID: 21072184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in drug transporter genes (ABCB1, SLCO1B1 and ABCC2) and hepatitis induced by antituberculosis drugs.
    Kim SH; Kim SH; Lee JH; Lee BH; Kim YS; Park JS; Jee YK
    Tuberculosis (Edinb); 2012 Jan; 92(1):100-4. PubMed ID: 22178260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke.
    Zhang L; Lv H; Zhang Q; Wang D; Kang X; Zhang G; Li X
    Curr Pharm Des; 2019; 25(14):1663-1670. PubMed ID: 31298164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.
    Merćep I; Radman I; Trkulja V; Božina T; Šimičević L; Budimir E; Ganoci L; Božina N
    Eur J Clin Pharmacol; 2022 Feb; 78(2):227-236. PubMed ID: 34668025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Chen R; Wang J; Tang S; Zhang Y; Lv X; Wu S; Xia Y; Deng P; Ma Y; Tu D; Chen D; Zhan S
    Tuberculosis (Edinb); 2015 Jan; 95(1):68-74. PubMed ID: 25498879
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhu M; Chen X; Hao Z; He Y; Han B; Tang S
    Pharmacogenomics; 2023 Dec; 24(18):931-942. PubMed ID: 38019119
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav-Related Liver Injury.
    Alshabeeb M; Alomar FA; Khan A
    Front Pharmacol; 2022; 13():882962. PubMed ID: 35754504
    [No Abstract]   [Full Text] [Related]  

  • 15. Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population.
    Jiang J; Zhang X; Huo R; Li X; Yang Y; Gai Z; Xu M; Shen L; Cai L; Wan C; Li B; He L; Qin S
    Pharmacogenomics J; 2015 Aug; 15(4):326-31. PubMed ID: 25446781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China.
    Wang T; Sun L; Xu L; Zhao T; Feng J; Yu L; Wu J; Li H
    Lipids Health Dis; 2021 Sep; 20(1):116. PubMed ID: 34563206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between ABCG2 and SLCO1B1 polymorphisms and adverse drug reactions to regorafenib: a preliminary study
.
    Maeda A; Ando H; Ura T; Komori A; Hasegawa A; Taniguchi H; Kadowaki S; Muro K; Tajika M; Kobara M; Matsuzaki M; Hashimoto N; Maeda M; Kojima Y; Aoki M; Kondo E; Mizutani A; Fujimura A
    Int J Clin Pharmacol Ther; 2017 May; 55(5):409-415. PubMed ID: 28157071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity.
    García Gil S; Ramos Díaz R; Nazco Casariego GJ; Llanos Muñoz M; Viña Romero MM; Martín Calero B; Pérez Pérez JA; Gutiérrez Nicolás F
    Med Clin (Barc); 2018 Dec; 151(11):425-430. PubMed ID: 29499902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury.
    Huang YS; Su WJ; Huang YH; Chen CY; Chang FY; Lin HC; Lee SD
    J Hepatol; 2007 Jul; 47(1):128-34. PubMed ID: 17400324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females.
    Li W; Liu W; Wang X; Dou R; Zhu Z
    Biochem Genet; 2024 Feb; 62(1):385-394. PubMed ID: 37355503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.